Atracurium Besylate Injection, Solution
Product Images NDC 0409-1105

This is a description of a medication called Atracurium Besylate Injection USP. The medication is intended for intravenous injection only and comes in a 10 mL multiple dose vial with a concentration of 100 mg/10 mL (10 mg/mL). The medication is sterile, non-pyrogenic, and manufactured by Gland Pharma Limited for Hospira, Inc. It is important to note that the medication is a paralyzing agent and may cause respiratory arrest, so facilities must be immediately available for artificial respiration if needed. The medication should be refrigerated and not frozen, and should be used within 14 days after being taken out of refrigeration, even if it is re-refrigerated. There is important information regarding the manufacturer's name and address, lot number, and the warning to discard the medication. The last line mentions an area size of 23 x 9mm.*

This is a description of a medication called Atracurium Besylate Injection USP, containing 100mg/10mL (10mg/mL). The drug is manufactured by Gland Pharma Limited in India, and is distributed by Hospira, Inc. in the USA. The product is a paralyzing agent for intravenous injection and comes in vials. The drug contains benzyl alcohol and is to be stored at 2-8°C (36-46°F). The pH of the drug is adjusted with benzenesulfonic acid. It is important to note that respiratory arrest may occur, and artificial respiration facilities should be available. Further dosage instructions can be found in the package insert.*

This is a description of Atracurium Besylate Injection USP, a medication used as a paralyzing agent during surgeries. It is manufactured by Gland Pharma Limited in India and comes in a packaging of 10x5 mL single-dose vials. It is important to note that facilities must have artificial respiration available and that the medication should be refrigerated and protected from light. The package insert should be consulted for recommended dosages. Batch details and 2D barcode can be printed online.*